Forest Hill Capital’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-37,000
Closed -$105K 37
2025
Q3
$105K Hold
37,000
0.06% 37
2025
Q2
$139K Hold
37,000
0.1% 36
2025
Q1
$168K Buy
+37,000
New +$196K 0.13% 38

Other funds holding HCAT

Forest Hill Capital's HCAT Position: Q4 2025 in Review

Forest Hill Capital sold out of Health Catalyst (HCAT) in Q4 2025, closing a stake of 37,000 shares — an estimated $105K sold.

Forest Hill Capital first reported a position in HCAT in Q1 2025 and held it in 3 quarters. The position peaked at $168K in Q1 2025. 136 funds tracked by Wall St. Rank hold HCAT as of Q4 2025.

  • Forest Hill Capital reported no remaining Health Catalyst position as of Q4 2025 after selling out during the quarter.
  • Forest Hill Capital sold 37,000 Health Catalyst shares in Q4 2025, an estimated $105K.
  • Forest Hill Capital first reported a position in Health Catalyst in Q1 2025 and held it in 3 quarters.
  • Forest Hill Capital's Health Catalyst position peaked at $168K in Q1 2025.
  • 136 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2025.

Based on Forest Hill Capital's 13F filing for Q4 2025, filed 17 Feb 2026.